CLINICAL_TRIALS
withdrawal
· 2012-06-01
Clinical Trial Update: Anti-psychotic Medication (Stable Dose) Weight Loss Study [Phase 2]
Summary
A Phase 2 trial evaluating an anti-psychotic medication for obesity was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avera McKennan Hospital & University Health Center | Conditions: Obesity | Phase 2 | Status: WITHDRAWN